Study of Toripalimab for Limited-Stage Small Cell Lung Cancer Following Concurrent Chemoradiotherapy
Condition: Small Cell Lung Cancer Limited Stage Intervention: Drug: Toripalimab Sponsors: Sun Yat-sen University; The First Affiliated Hospital of Guangzhou Medical University; Guangzhou Panyu Central Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials